English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/139907
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Optimization of a class of tryptophan dendrimers that inhibit HIV replication leads to a selective, specific, and low-nanomolar inhibitor of clinical isolates of enterovirus A71

AuthorsRivero-Buceta, Eva ; Sun, L.; Martínez-Gualda, B.; García Doyagüez, Elisa; Donckers, K.; Quesada, Ernesto; Camarasa Rius, María José ; Delang, Leen; San-Félix, Ana ; Neyts, Johan; Leyssen, Pieter
Issue Date2016
PublisherAmerican Society for Microbiology
CitationAntimicrobial Agents and Chemotherapy 60: 5064-5067 (2016)
AbstractTryptophan dendrimers that inhibit HIV replication by binding to the HIV envelope glycoproteins gp120 and gp41 have unexpectedly also proven to be potent, specific, and selective inhibitors of the replication of the unrelated enterovirus A71. Dendrimer 12, a consensus compound that was synthesized on the basis of the structure-activity relationship analysis of this series, is 3-fold more potent against the BrCr lab strain and, surprisingly, inhibits a large panel of clinical isolates in the low-nanomolar/high-picomolar range.
Identifiersdoi: 10.1128/AAC.00626-16
issn: 0066-4804
e-issn: 1098-6596
Appears in Collections:(CENQUIOR) Artículos
Files in This Item:
File Description SizeFormat 
Antimicrob. Agents Chemother.-2016-Rivero-Buceta-5064-7.pdf417,82 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.